Forager says ‘committed’ to pursuing Quipt Home Medical transaction

Forager Capital Management, one of the largest shareholders of Quipt Home Medical (QIPT), with beneficial ownership of 9.7% of the outstanding shares, issued the following statement: “On May 17, 2025 – nearly sixteen weeks ago – Forager submitted an offer to acquire Quipt for $3.10 per share in cash. Had Quipt’s Board constructively engaged, the transaction could have been completed by now under the timeline outlined in the May Offer. Shareholders would have locked in a 120% return in under six months – a gain that could have already been redeployed into new opportunities. Every day the Board delays further reduces the IRR for shareholders, a key metric by which performance is judged. For context, Houlihan Lokey reported that take-private transactions in 2024 saw an average premium of 37.5%, with a peak premium of 106%. Forager’s offer – a 120% premium to Quipt’s unaffected share price prior to the May Offer – would exceed every transaction in the report and is more than three times the average. We remain committed to pursuing a transaction that delivers immediate and compelling value to all Quipt shareholders. We reiterate our willingness to improve our offer upon constructive engagement from the Board.”